Patients can now receive interventional techniques that are no longer palliative in nature,” stated Samir Khan, DO, provider ...

As an orthopedic and sports medicine surgeon and chairman at Inova Sports Medicine, Dr. Robin West is no stranger to sports-related injuries. She understands that developing an effective game plan to ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

The following is a summary of “Underutilized treatments for patients with refractory cancer pain: A qualitative study assessing the use of intrathecal drug delivery devices in the United Kingdom ...

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

A local vascular surgeon has highlighted a simple injection that could alleviate leg pain for those experiencing heaviness or ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

HCB Benidorm Hospital inaugurates its new Pain Unit, in collaboration with the expert group in Pain treatments, MIVI Salud, with whom it already works at HCB Dénia.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Milestone Scientific (MLSS) announced the commercial implementation of its CompuFlo Epidural System at Pain Doctors Medical, a specialized ...